A veteran British beauty editor recently documented her experience as the first UK journalist to undergo Alidya treatments. Developed by Italian plastic surgeon Professor Pasquale Motolese, this injectable procedure aims to address the structural causes of cellulite rather than just surface-level skin tightening.

Advertisement

The 90% statistic and the menopause connection

Cellulite is a structural condition that affects up to 90% of women,driven by the way fat pushes against vertical fibrous bands. As the report notes, this condition is often exacerbtaed by menopause, as fluctuating hormones lead to increased fat deposition in the hips and thighs while simultaneously thinning the skin. This biological shift makes the "orange-peel" texture more pronounced, as the skin loses the collagen necessary to maintain firmness.

The biological impact of cellulite also differs significantly between genders. While women are prone to the condition due to vertical fibrous bands, men possess a criss-cross pattern of these fibers that holds fat more evenly in place. This anatomical difference explains why the dimpled appearance is much more prevalent in female patients.

Shifting from body brushing to Professor Motolese's injections

For decades, the primary response to cellulite has been low-tech and often underwhelming, such as daily body brushing. While these mechanical methods might offer slight textural changes, they rarely provide the meaningful results many consumers seek.. The introduction of Alidya represents a shift toward biochemical intervention rather than simple skin manipulation.

The Alidya treatment, created by Professor Pasquale Motolese, moves away from traditional skin-tightening methods to address the underlying biological drivers of the condition. instead of merely shrinking fat cells, the injectable solution targets oxidative stress and fibrosis—the gradual stiffening of the collagen bands beneath the skin. According to the article, the treatment also aims to assist lymphatic drainage and help eliminate heavy mettals that can accumulate in the tissues.

Seventy injections per thigh and a £250 price tag

The Alidya procedure is a precise and intensive process, requiring approximately 70 small injections per buttock and upper thigh. These injections are administered just beneath the skin using fine needles. The solution itself is a complex blend of amino acids intended to restore skin elasticity, alongside antioxidants like calcium ascorbate to neutralize oxidative stress.

Patients undergoing this regimen can expect a commitment of rouhgy seven sessions, spaced one week apart. Each individual treatment is reported to cost from £250. While the journalist in the report observed visible improvements after six sessions, full results are typically expected to manifest a few weeks after the final treatment is completed.

The limits of a single journalist's six-session trial

A significant question remains regarding whether the results observed by a single beauty editor can be replicated across a broader, more diverse demographic. The report focuses on one person's successful experience—noting visible improvements following a holiday to Sweden—but leaves several variables unaddressed. It is currently unknown if the long-term durability of these results can be maintained or if there are specific side effects associated with the amino acid injections.

Furthermore, the claim that the treatment helps eliminate heavy metals from the tissues remains an unverified point in the context of wider medical consensus. Until larger-scale clinical studies are published, it is difficult to determine if Alidya's biological approach is a permanent solution or a high-cost temporary fix.